Design and construction of novel pyridine-pyrimidine hybrids as selective COX-2 suppressors: anti-inflammatory potential, ulcerogenic profile, molecular modeling and ADME/Tox studies
Design and construction of novel pyridine-pyrimidine hybrids as selective COX-2 suppressors: anti-inflammatory potential, ulcerogenic profile, molecular modeling and ADME/Tox studies
Impact of Some Natural and Artificial Sweeteners Consumption on Different Hormonal Levels and Inflammatory Cytokines in Male Rats: In Vivo and In Silico Studies
A structure-based approach to explore novel COX-2 inhibitors using pharmacophore modelling, 3D-QSAR analysis, virtual screening and dynamics simulation study
Novel Adaptable HPLC Method for Pharmacokinetic Study of New Pioglitazone Synthetic Analogue: Greenness Assessment
2024 - 2025
“n silico studies, synthesis, and pharmacological screening of novel multitarget molecules; new
2024 - 2025
In silico studies, synthesis, and pharmacological screening of novel multitarget molecules; new scaffold targeting cancer, inflammation diabetes, or/ and parkinsonism.
2024 - 2025
“Anticancer or/ anti-inflammatory activities ; Design, semi-synthesis, synthesis and structur
2024 - 2025
Education
Ph.D.
cairo - pharmaceutical organic chemistry
2008 - 2005
BA
cairo - pharmacy
1996 - 1991
M.A.
cairo - pharmacy
2005 - 2005
Experience
associate professor
, college of pharmacy Jouf university SA
2015 - 2019
assistant professor of pharmaceutical organic chemistry ,